-
Type:
EC eCQMs - Eligible Clinicians
-
Resolution: Referred to External Party for Resolution
-
Priority:
Moderate
-
Component/s: None
-
None
-
-
Not measure related
-
CMS0145v14, CMS0156v14
-
CMS0145v13, CMS0156v13
-
CMS0145v12, CMS0156v12
I am seeking clarification regarding final measurement period scoring for CMS 145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%) and CMS 156: Use of High-Risk Medications in Older Adults. For CMS 145, does CMS apply stratifications when scoring the measure for the final measurement period? If so, which stratification is used for scoring purposes? If stratifications are not applied, should we assume the measure is scored using CMS 145.1? Similarly, for CMS 156, does CMS use stratifications for final measurement period scoring? If so, which stratification is applied? If not, please confirm whether the measure is scored using CMS 156.1.Thank you for your guidance and clarification.